NanoGroup S.A. Logo

NanoGroup S.A.

Develops nanotechnology-based medical solutions for oncology and transplantology.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa

Description

NanoGroup S.A. is a biotechnology company specializing in the application of nanotechnology to medicine. The company focuses on developing and licensing early-stage, pre-clinical, and Investigational New Drug (IND) solutions. Its research and development activities are concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key areas of interest include innovative anticancer therapies utilizing RNA, regenerative medicine, early diagnostics, and the development of advanced organ perfusion systems for transplantation.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-15 19:42
Zawarcie i opłacenie umowy objęcia akcji serii N przez ECAPITAL sp. z o.o. - Co…
Polish 3.2 KB
2025-12-15 19:36
Zawiadomienie
Polish 83.9 KB
2025-12-15 19:36
Zawiadomienie w trybie art. 69 ustawy o ofercie publicznej - Content (PL)
Polish 694 bytes
2025-12-15 19:33
Zawiadomienie
Polish 78.7 KB
2025-12-15 19:33
Zawiadomienie w trybie art. 69 ustawy o ofercie publicznej - Content (PL)
Polish 708 bytes
2025-12-15 19:31
Zawiadomienie
Polish 83.9 KB
2025-12-15 19:31
Zawiadomienie w trybie art. 69 ustawy o ofercie publicznej - Content (PL)
Polish 687 bytes
2025-12-15 19:28
Zawiadomienie
Polish 78.7 KB
2025-12-15 19:28
Zawiadomienie w trybie art. 69 ustawy o ofercie publicznej - Content (PL)
Polish 701 bytes
2025-12-11 17:24
Otrzymanie zawiadomienia o zakończeniu procesu sprzedaży posiadanych akcji - Co…
Polish 4.6 KB
2025-12-09 17:28
Zawiadomienie od akcjonariusza Spółki o rozpoczęciu procesu sprzedaży posiadany…
Polish 5.3 KB
2025-11-27 17:16
Raport 2025Q3
Polish 1.1 MB
2025-11-27 17:10
Raport 2025Q3
Polish 1.1 MB
2025-11-21 08:55
Strategia 2026-2028
Polish 2.1 MB
2025-11-21 08:55
Strategia Rozwoju NanoGroup S.A. na lata 2026-2028 - Content (PL)
Polish 2.6 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NanoGroup S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.